clarithromycin has been researched along with Cachexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awan, S; Baldwin, D; Crosby, V; Hennig, I; Ndlovu, M; Paradine, S; Potter, V; Wilcock, A | 1 |
| Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M | 1 |
1 trial(s) available for clarithromycin and Cachexia
| Article | Year |
|---|---|
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Topics: Aged; Biomarkers; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Combined Modality Therapy; Disease Progression; Female; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Protein Synthesis Inhibitors; Survival Analysis; Treatment Outcome; Weight Gain | 2001 |
1 other study(ies) available for clarithromycin and Cachexia
| Article | Year |
|---|---|
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study.
Topics: Anti-Bacterial Agents; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Feasibility Studies; Female; Humans; Lung Neoplasms; Macrolides; Male; Medication Adherence; Neoplasm Staging; Placebos; Randomized Controlled Trials as Topic | 2017 |